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The subcellular distribution of multiple molecular forms of acetylcholinesterase (AChE) in neurones of rat 
superior cervical ganglion (SCG) was determined both in vivo and in vitro by the use of selective lipid- 
soluble or -insoluble inhibitors. In vivo as well as in vitro, IO S AChE is mainly outside the cell. In primary 
cultures of rat SCG neurones, both 4 S and 16 S AChE are mainly inside the cell. In near-term rat SCG, 
4 S and 16 S are more external to the cell than in primary cultures. In adult rat SCG, 4 S AChE is equally 
distributed inside and outside and 16 S AChE is mainly outside the cell. Thus, specific AChE externalization 
probably occurs in neuronal cells as a developmentally regulated process. 
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1. INTRODUCTION 
Acetyl~holinesterase (AChE; EC 3.1.1.7) is 
found in many neuronal and non-neuronai tissues 
and can be resolved into several active molecular 
forms (reviews [1,2]). Although there have been 
many studies on the localization of AChE in mus- 
cle in vivo and in vitro [3], much less is known on 
the details of its biosynthesis, intracellular 
transport and secretion in neuronal cells. In rat 
superior cervical ganglia (SC@, 5 molecular forms 
of AChE exist in vivo as well as in vitro (4 S, 6.5 S, 
10 S, 12 S and 16 S) f4,5]. The AChE sedimenta- 
tion profiles differ, depending on the developmen- 
tal stages reached by the neuronal cells. These 
forms belong to two main structural types cor- 
responding to globular and tailed, asymmetric 
species first described for electric fish AChE 
[2,6-81. Moreover, in addition to the collagen-like 
tail, other non-catalytic components may con- 
tribute to asymmetric AChE [9]. Not only globular 
forms (10,l I] but also asymmetric forms possess 
hydrophilic and hydrophobic variants [12,13]. 
Such polymorphic features and diverse physico- 
chemical properties suggest that AChE may in- 
teract with, and be localized in, different cell com- 
partments or cellular structures. In this paper, we 
identify and describe the intracellular and ex- 
traceliular pools of AChE forms in sympathetic 
neurons in vivo and in culture conditions. 
2. MATERIALS AND METHODS 
We used highly lipid-soluble and poorly lipid- 
soluble inhibitors of AChE: phospholine (eco- 
thiopate iodide) (Promedica, France), a charged, 
poorly lipid-soluble irreversible inhibitor of exter- 
nal AChE, and MPT (0-ethyl-~~-diisopropyl- 
aminoethylmethylphosphorothiolate} (a gift from 
Dr F. Leterrier, HGpital Percy, Clamart), a highly 
lipid-soluble, irreversible inhibitor. BW 284 C5f 
(15 - bis(4 - allyldimethylammoniumphenyl)pentane - 
3-one dibromide) (Burroughs Wellcome) is poorly 
lipid-soluble and reversible. It inhibits AChE out- 
side the cell. We studied the subcellular distribu- 
tion of the multiple molecular forms of rat SCG 
AChE in 3 different systems: in vivo, in near-term 
(E21; embryonic day 21) and adult SCG and in 
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vitro, in &day-old primary cultures, obtained as 
previously described [5], in the presence of nerve 
growth factor (7 S NGF, 1 ,ug/ml) [14]. All incuba- 
tions were performed in the culture medium [S]. In 
the inhibition experiments with phospholine, 
10e5 M phospholine was applied for 3 min. After 
3 washes in the basal medium, the ganglia or cells 
were further analyzed for AChE. In the protection 
experiments, 10e4 M BW 284 C51 was applied for 
15 min, followed by BW + 1.5 x lo-’ M MPT for 
15 min, and 3 washes followed, the first one in the 
presence of BW. Then, the ganglia were collected 
or cells scraped for AChE analysis. AChE activity 
was expressed in pmol acetylthiochoiine hydro- 
lyzed/h per ganglion or per culture dish. Sedimen- 
tation analysis was performed and quantitative 
data collected for the 3 main AChE peaks, i.e., 4 S 
+ 6.5 S, 10 S + 12 S and 16 S. We have previously 
shown that AChE activity in such cultures is 
present in the sympathetic neurones themselves [5]. 
3. RESULTS 
Phospholine or BW + MPT were applied to ex- 
cised near-term (E21) rat SCG kept in basal 
medium as described in section 2. Table 1 gives the 
total AChE activities on a per ganglion basis in 
control, BW + MPT or phospholine-treated 
samples. There are roughly similar amounts of ex- 
tracellular and intracellular AChE. Fig. la shows 
the sedimentation patterns of AChE present in 
control or treated ganglia. The BW + MPT treat- 
ment results in an important decrease of 4 S AChE 
(4 S plus a minor 6.5 S component) and 16 S 
AChE (43 and 42.7% of their control activities, 
respectively); 10 S AChE (10 S plus a minor 12 S 
component) is less affected (74.3% of control ac- 
tivity) (table 2). In contrast, the phospholine treat- 
ment shows an important decrease of 10 S AChE 
(35.5% of control activity); 4 S and 16 S AChE are 
less affected (70.3 and 76.1% of control values, 
respectively). These results suggest hat 10 S AChE 
is predominantly extracellular and 4 S and 16 S 
AChE are mostly internal in the neonatal SCG 
neurones. 
The same treatments were applied to adult rat 
SCG. Total AChE activity was also expressed on a 
per ganglion basis, and the BW i- MPT or 
phospholine treatments how that AChE is mainly 
extracellular (remaining activities: 60.4% after BW 
+ MPT and 30.4% after phospholine) (table 1). 
Fig. 1 b shows the sedimentation profiles obtained 
in the same experiments. After BW + MPT treat- 
ment, the 4 S activity is decreased (48.6% of con- 
trol), the 10 S and 16 S forms being less affected 
(67.0 and 70.6% of control, respectively) (table 2). 
The phospholine treatment differently affects the 
AChE forms since the activities of the 4 S, 10 S 
and 16 S forms represent 33.7, 24.5 and 39.7% of 
their control values, respectively. Thus, 4 S AChE 
is equally distributed in intra- and extracellular 
compartments and 10 S and 16 S AChE are mainly 
external in these adult SCG neurones. 
BW + MPT or phospholine were further applied 
to primary cultures of neonatal SCG neurones. In 
8-day-old cultures, total AChE activities expressed 
on a per dish basis are affected in the same manner 
by BW + MPT or phospholine (45.6 and 44.7% of 
control, respectively) indicating that the pools of 
extracellular and intracellular AChE are roughly 
the same as in the neuronal cells (table 1). Fig.lc 
shows the sedimentation patterns of AChE after 
BW + MPT, the remaining activity of 4 S, 10 S 
and 16 S AChE are 27.2, 56.9 and 18.7% of their 
control values, respectively. Correspondingly, the 
4 S and 16 S forms are not affected by the 
phospholine treatment (116.6 and 108.3% of con- 
trol values, respectively) whereas the 10 S activity 
is very much decreased (23.4% of remaining activi- 
ty) (tabIe 2). These results suggest hat the 4 S and 
16 S forms have an internal location, and that the 
10 S form is more external in in vitro conditions. 
Table 1 
Effect of inhibitors on total AChE activity in near-term (E21) 
and adult rat SCG and in SCG primary cultures 
Control BW + MPT Phospholine 
AChE activity AChE activity AChE activity 
@molfh per (Bio of (Vo of 
ganglion or control) control) 
dish) 
E21 
Adult 
Culture 
353 f 31 53.7 rt: 4.1 61.3 k 6.4 
n=4 n= 4 n=4 
4660 t 243 60.4 r 5.0 30.4 F 6.4 
n=4 n= 5 n=5 
1132 f 81 45.6 + 5.6 44.7 I 3.5 
n=9 n = 10 n=7 
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Fig.1. Sedimentation profiles of AChE extracted from: 
(a) near-term rat SCG (E21; embryonic day 21), (b) adult 
rat SCG and (c) primary cultures of rat SCG. Ahquots 
of homogenates (in 1 M N&l, 0.001 M EGTA, Q,Ol M 
Tris-HCI, pH 7.2, and 1% Triton x-100) were 
centrifuged at 176500 x g for I5 h at 4°C on 5-20% 
(w/v) sucrose gradients. AChE activity was measured by 
the method of Ellman et al. [20]. (A--+) Control, 
(X-X) BW + MPT-treated celb and (G----0) 
phospholine-treated cells. The arrows indicate the 
position of sedimentation markers: yeast alcohol 
dehydrogenase (ADH, 7.4 SZO,~), catalase (Cat, 
11.3 SZO,.,+), fi-galactosidase (GZ, 16 ~20,~). Three main 
peaks are observed: (4+6.5) S, (LO+ 12) S and 16 S 
from right to left. The first and second peaks possess 
shoulders indicating minor 6.5 S and 12 S contributions 
fRRC?iOM NUMeER to the 4 S and 10 S AChE forms ]21]. 
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Table 2 
Effect of inhibitors on the activity of the different molecular forms of AChE 
E21 
Adult 
Culture 
AChE activity 
(= 100%) 
control 
(4+6.5) (10+12) 16 S 
S s 
1.20 1.69 1.85 
+- 0.04 * 0.13 Ifr 0.13 
100% 100% 100% 
25.42 29.67 8.05 
+ 2.16 f 1.65 zt 1.14 
100% 100% 100% 
2.53 10.49 2.28 
f 0.26 + 0.31 zfr 0.26 
100% 100% 100% 
BW + MPT Phospholine 
AChE activity (070 AChE activity (olo 
of control) of control) 
(4+6.5) (10+12) 16 S (4+6.5) (10+12) 16 S 
S S S S 
43.0 74.3 42.7 70.3 35.5 76.1 
i 5.4 t 4.7 F 4.2 * 3.5 f 3.5 + 12.7 
48.6 67.0 70.6 33.7 24.5 39.7 
* 3.8 Yk 7.5 +: 7.8 III 7.0 f 5.7 + 11.0 
27.2 56.9 18.7 116.6 23.4 108.3 
+ 4.8 + 6.7 + 2.9 + 12.7 k 1.3 + 14.8 
4. DISCUSSION 
The aim of this work was to study the cellular 
localization of AChE in sympathetic neurones and 
characterize the extra- and intracellular pools of 
AChE and its main molecular forms, 4 S, 10 S and 
16 S. External and internal cell compartments can 
be determined by the use of poorly or highly lipid- 
soluble, reversible or irreversible inhibitors of 
AChE [IS]. The poorly lipid-soluble inhibitors 
which were chosen are phospholine and BW 
284 C51. These inhibitors are not perfectly non- 
permeative. Consequently some quantities of these 
inhibitors will enter into the cell leading to approx- 
imate measurements of the extra- and intraceIlular 
pools. In the near-term SCG in vivo we found 
equal amounts of AChE inside and outside the 
cell, with 4 S and 16 S AChE essentially located in- 
side the cell (70-75070). In contrast, 10 S AChE is 
prevalent outside the cell. The importance of the 
internal pool of4 S and 16 S AChE suggests that 
not only 4 S but also 16 S AChE are synthesized 
and preassembled intracellularly, a proposition in 
agreement with recent results on muscle cells 
[3,12,16]. In the adult SCG, AChE is slightly more 
extracellular than intracellular (60~0). The 4 S 
form is equally distributed outside and inside the 
cell and 10 S and 16 S AChE are mostly in the ex- 
ternal compartment (70~0). In comparison with 
the embryonic situation there is much more 16 S 
AChE outside the cells in adult ganglia. Accord- 
ingly, in adult rat anterior gracilis muscle, 85% of 
16 S AChE is in an extracellular environment 
[ 16,171. In SCG, a major external ocation of 16 S 
AChE is observed only at the adult stage and may 
thus occur as a consequence of further postnatal 
maturation of the sympathetic neurones. The 
results obtained in vitro with primary cultures of 
SCG are rather different from those obtained with 
SCG in vivo. We found that the AChE activity is 
equally distributed inside and outside the cultured 
cells. Neuronal 10 S AChE is more important in 
the external compartment, as in the near-term rat 
SCG. But 4 S and 16 S AChE are mainly inside the 
cel1. In our culture conditions, SCG neurones are 
capable of dual cholinergic-noradrenergic neuro- 
transmitter production [18,19], and may be in a 
rather undifferentiated state. When adrenergic dif- 
ferentiation and maturation occur as it does in 
vivo, an increasing proportion of the cellular 4 S 
and 16 S AChE becomes externalized. It would be 
interesting to know whether the process of exter- 
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nalization of AChE is directly related to noradre- 
nergic differentiation. 
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